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Background Allergy to natural rubber latex is a well-recognized health problem,
especially among health care workers and patients with spina bifida. Despite latex
sensitization being acquired in health institutions in both health care workers
and patients with spina bifida, differences in allergen sensitization profiles have
been described between these two risk groups.
Objective To investigate the in vivo reactivity of health care workers and patients
with spina bifida to extracts of internal and external surfaces of latex gloves and
also to specific extracts enriched in major allergens for these risk groups.
Methods Gloves from different manufacturers were used for protein extraction, and
salt precipitation and hydrophobic interaction chromatography (HIC) were
applied to obtain the enriched latex extracts. The major latex allergens were
quantified by an enzyme immunoassay. The extracts obtained were tested in 14
volunteers using skin prick tests (SPT).
Results Latex glove extracts enriched in the hydrophobic allergens that are most
often seen in patients with spina bifida were obtained by selective precipitation,
whereas HIC produced extracts enriched in the hydrophilic allergens commonly
found in health care workers. The health care workers had positive SPTs to glove
extracts from internal surfaces and to the hydrophilic allergen-enriched extracts.
By contrast, patients with spina bifida had larger skin reactions both to external
glove extracts and to the extracts enriched with the hydrophobic major allergens
for this risk group. Despite the protein concentration of these extracts being less
than half the concentration of the commercial extract, the weal-and-flare
reactions were of similar magnitude.
Conclusion Using novel latex extracts, our study showed a different in vivo reactivity
pattern in health care workers and in patients with spina bifida to extracts of the
internal and external surfaces of gloves, which suggests that sensitization may
occur by different routes of exposure, and that this influences the allergen
reactivity profiles of these risk groups.
Allergy to natural rubber latex (NRL) is a significant medical
and occupational public health problem, especially for health
care workers and patients with spina bifida, with an exponen-
tial increase in prevalence in the 1980s and 1990s, possibly
due to the drastic increase in glove usage in response to
concerns about AIDS and other infectious diseases.1–3 Over the
past 10 years, latex sensitization and allergy in health care
workers have decreased because of avoidance practices that
include a latex-reduced environment by wearing powder-free
latex gloves and synthetic latex-free gloves in health institu-
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tions.4–7 However, despite significant progress in the manage-
ment of the disease, the prevalence values of NRL allergy in
health care workers and patients undergoing multiple surgery,
such as patients with spina bifida, are 3–17% and 40–50%,
respectively.3,8
Although latex sensitization is mainly acquired in health
institutions by both patients with spina bifida and health care
workers, these risk groups may have different sensitization
profiles to latex allergens. In fact, whereas major allergens for
patients with spina bifida are hydrophobic (Hev b 1 and Hev
b 3), major allergens for health care workers are hydrophilic
(Hev b 2, Hev b 5, Hev b 6Æ01 and Hev b 13).9–11 Although
genetic factors may be involved,12,13 environmental exposure
to natural rubber latex products is necessary for sensitization
in both risk groups.14
In this context, the different reactivity profiles observed
between health care workers and patients with spina bifida
may be partly due to different direct environmental exposures,
namely the different allergen composition of the internal and
external surfaces of latex gloves.15–17
The purpose of this work is to study, for the first time, the
in vivo reactivity of health care workers and patients with spina
bifida to extracts from the internal and external surfaces of
gloves to determine whether the sensitization profiles are
related to their different exposures to the latex glove surfaces.
Bearing in mind the paradigm of hydrophobic major allergens
in patients with spina bifida vs. hydrophilic major allergens in
health care workers, the effectiveness of selective precipitation
and hydrophobic interaction chromatography (HIC) to produce
enriched allergen fractions from latex was also explored. In
order to obtain the real allergome, closer to the source of sensi-
tization of health care workers and patients with spina bifida,
we aimed to develop a process for the generation of extracts
enriched in the major latex allergens from latex gloves and to
assess in vivo the sensitization to these specific extracts. It was
also our goal to assess the adequacy of different latex glove
extracts produced in the study (internal, external and extracts
enriched in the major latex allergens) for in vivo skin tests.
Materials and methods
Glove extracts
To obtain the NRL glove extracts, six different glove brands
were collected from health institutions in Portugal, during
2009. Extraction of proteins from the gloves was performed
on a bath, for 24 h at 37 C, using 200 mL of phosphate-
buffered saline (PBS) and 20 g of glove. After extraction, the
rubber products were removed and the extracts were centri-
fuged at 4000 g for 10 min, filtered through 0Æ45-lm mem-
branes and ultra-concentrated on an AMICON unit with
membranes NMWL 1000 Da (Millipore, Billerica, MA,
U.S.A.). Dialysis against water was performed on a Pierce
Snakeskin Pleated NMWL 3500 Da membrane (Pierce, Rock-
ford, IL, U.S.A.). The product was then lyophilized, and stored
frozen ()20 C) for further analysis.
External glove surface extracts were prepared by sealing the
proximal wrist end. Extracts of internal surfaces of the gloves
were prepared in the same way after turning internal surfaces
out. Extracts for selective precipitation and HIC experiments
were obtained from whole gloves cut into pieces. To avoid
cross-contamination of NRL allergens, vinyl gloves were worn
for all laboratory procedures.
Fractionation of glove extracts by ammonium sulphate
precipitation
Three hundred milligrams of lyophilized latex glove extract
were dissolved in 20 mmol L)1 tris-HCl, pH 7Æ5. A precipita-
tion step was performed by using 25% ammonium sulphate.
After being stirred for 30 min, at 4 C, the precipitated extract
(denoted P1) was centrifuged at 12 000 g for 15 min, at
4 C. The same process was repeated after adding 50% and
75% ammonium sulphate (precipitated extracts were denoted
P2 and P3, respectively). The extracts obtained from the three
precipitation steps were dialysed against water, lyophilized
and were stored at )20 C.
Hydrophobic interaction chromatography
HIC was performed using a fast protein liquid chromatography
(FPLC) system (GE Healthcare Biosciences, Uppsala, Sweden)
on a Sepharose CL-6B column modified with butyl-1,4-bis-
(2,3-epoxy-propoxyd), prepared in our laboratory according
to Queiroz et al.18 The gel was packed in an XK column 16 ⁄20
(GE Healthcare Biosciences) and equilibrated with PBS
0Æ01 mol L)1, with ammonium sulphate, 1Æ0 mol L)1, pH 7Æ4.
An injection of latex glove extract (100 lL) was loaded onto
the column at a flow rate of 1 mL min)1 and the absorbance
of the eluate was continuously monitored at 280 nm. Elution
was carried out with PBS 0Æ01 mol L)1, pH 7Æ4. Extracts
obtained previously by selective precipitation, P1, P2 and P3,
were also loaded onto the column in a series of experiments
with different eluent composition. The column was equili-
brated with PBS 0Æ01 mol L)1, pH 7Æ4, with concentrations of
ammonium sulphate in the eluent varying between 0Æ5 and
1Æ5 mol L)1. Elution was carried out using PBS 0Æ01 mol L)1,
pH 7Æ4. Fractions were concentrated, dialysed against water
and lyophilized as previously described.16 All assays were per-
formed at room temperature.
Capture enzyme immunoassay for quantiﬁcation of
allergens
Quantification of Hev b 1, Hev b 3, Hev b 5 and Hev b 6Æ02
was performed using a commercial Kit (FITkit, IcoSagen,
Tartu, Estonia) according to the manufacturer’s instructions.
The detection limit levels of allergens on FITkit were: Hev b
1, 1Æ2 lg L)1; Hev b 3, 2Æ3 lg L)1; Hev b 5, 0Æ5 lg L)1; Hev
b 6Æ02, 0Æ1 lg L)1. When allergen readings were below the
detection limit levels were denoted as zero. All assays were
performed in triplicate.
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Characterization of patients allergic to latex
Fourteen volunteers (seven health care workers and seven
patients with spina bifida) diagnosed as having latex allergy,
with a consistent clinical history, were recruited for the study.
The participants’ demographic and clinical characterizations
are described in Table 1.
Determination of allergen-speciﬁc IgE
Latex-specific IgE levels in the sera of the 14 patients were
measured using total latex extract k82 and recombinant Hev b
allergens (ImmunoCAPS, Phadia, Uppsala, Sweden).
Skin prick tests
Having obtained written informed consent from all patients
and subjects, skin prick tests (SPT) were performed in accor-
dance with recommendations of the European Academy of
Allergy and Clinical Immunology. The Ethics Committee of
the collaborating hospitals approved this study.
The allergenic components used for SPT included a com-
mercial latex extract (Laboratorios LETI SL, Tres Cantos,
Madrid, Spain; 1000 lg protein mL)1) and specially prepared
extracts from the interior and exterior surfaces of latex gloves,
and preparations enriched in the major allergens (400 lg pro-
tein mL)1) fractionated by selective precipitation of extracts
from patients’ gloves and by HIC from health care workers’
gloves. Tests were performed in duplicate on the volar surface
of both forearms. Histamine (0Æ1%; 10 lg mL)1) and PBS
were used, respectively, as positive and negative control
reagents. SPT sites were wiped clean after 15 min and the
weal and flare reactions were carefully recorded. Positive weal
and flare reactions (‡ 3 mm, in the presence of a negative
control) were outlined by a marker, transferred onto transpar-
ent tape and kept as a permanent record, after having
measured the mean weal diameter.
Results
Selective precipitation with ammonium sulphate
Proteins of the total glove extract were first fractionated by
selective precipitation using 25%, 50% and 75% ammonium
Table 1 Demographic and clinical characterization of health care worker participants and patients with spina bifida
Patients Sex ⁄Age








1. HCW Female 31 Nasal and ocular pruritus, wheezing, occasional
dyspnoea, cough and increased bronchial secretions
33Æ4 1Æ24 rHev b 8 (4Æ82)
2. HCW Female 40 Acute urticaria 20Æ3 6Æ53 rHev b 5 (4Æ55)
rHev b 6Æ01 (2Æ32)
rHev b 6Æ02 (2Æ32)
3. HCW Female 20 Nasal and ocular pruritus, urticaria 1Æ0 0Æ65 rHev b 8 (1Æ08)
4. HCW Female 45 Rhinoconjunctivitis, hand dermatitis, pruritus,
urticarial bouts
< 0Æ35 < 0Æ35 No serum reactivity
was detected
5. HCW Female 33 Nasal and ocular pruritus, sneezing bouts, urticarial
rashes, anaphylaxis
1Æ51 0Æ49 rHev b 8 (1Æ01)
6. HCW Female 34 Hand dermatitis, ocular and nasal pruritus n.d. 1Æ65 rHev b 5 (1Æ01)
rHev b 6Æ02 (0Æ63)
7. HCW Female 40 Nasal pruritus, hand oedema with pruritus n.d. 1Æ92 rHev b 5 (0Æ97)
rHev b 6Æ01 (0Æ75)
rHev b 6Æ02 (1Æ02)
8. PSB Female 20 Urticarial rashes, ocular and nasal pruritus, sneezing,
rhinoconjunctivitis
30Æ6 9Æ79 rHev b 1 (2Æ79)
rHev b 3 (2Æ47)
rHev b 5 (6Æ65)
9. PSB Female 17 Ocular and nasal pruritus 0Æ11 1Æ81 rHev b 1 (1Æ06)
rHev b 5 (0Æ37)
rHev b 6Æ01 (0Æ54)
10. PSB Female 22 Urticaria, thoracic discomfort 1Æ58 0Æ57 rHev b 6Æ01 (0Æ91)
11. PSB Male 15 Hands and face erythema, urticarial rashes, ocular
angio-oedema, ocular pruritus, pruritus hands
16Æ4 1Æ43 rHev b 3 (1Æ18)
12. PSB Female 23 Ocular pruritus with eyelid oedema, nasal pruritus,
thoracic discomfort, wheezing
n.d. 17Æ9 rHev b 1 (0Æ92)
rHev b 5 (61Æ7)
rHev b 6Æ01 (17)
13. PSB Male 18 Lips angio-oedema, ocular pruritus, urticaria < 0Æ35 < 0Æ35 No serum reactivity
detected
14. PSB Female 19 Asymptomatic 79Æ9 15Æ1 rHev b 5 (9Æ29)
aMultiallergen IgE antibody screen, cutoff 0Æ35 kUa L)1. bAllergen-specific IgE antibody test, cutoff 0Æ35 kUa L)1. n.d., not determined;
HCW, health care workers; PBS, patient with spina bifida
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sulphate in tris-HCl. The extract obtained with 25% of
ammonium sulphate (P1), denominated pPSB, showed enrich-
ment in the hydrophobic allergens Hev b 1 and Hev b 3 that
are major allergens for patients with spina bifida (Table 2),
despite the presence of Hev b 6Æ02 (5Æ10 lg L)1). Enzyme
immunoassay (EIA) quantification of Hev b 1 and Hev b 3
was 49Æ16 lg L)1 and 26Æ41 lg L)1, respectively. On the
other hand, extracts obtained using 50% and 75% of ammo-
nium sulphate (P2 and P3) had a mixture of hydrophilic
allergens (Hev b 5 and Hev b 6Æ02) and Hev b 1 (Table 2).
Hydrophobic interaction chromatography
HIC was applied to samples of total extracts from gloves,
loaded onto an epoxy support. Under the conditions used,
two peaks were resolved corresponding to unbound proteins
and were eluted with 1Æ0 mol L)1 ammonium sulphate in PBS
(peaks 1 and 2). Bound proteins were eluted (peak 3) by
subsequently decreasing ammonium sulphate concentration in
eluent buffer to 0 mol L)1, in a stepwise mode. Quantifica-
tion of the four major allergens Hev b 1, Hev b 3, Hev b 5
and Hev b 6Æ02 by EIA revealed that the first peak (denomi-
nated pHCW) contained only the hydrophilic allergens most
important in health care workers, Hev b 5 and Hev b 6Æ02
(Table 2). Analysis of peak 2 showed a latex fraction with
Hev b 1 at a two-fold concentration (12Æ50 lg L)1), when
compared with Hev b 6Æ02 (6Æ09 lg L)1), whereas peak 3
showed a mixture of Hev b 1, Hev b 3 and Hev b 6Æ02.
Briefly, HIC assays of total glove extracts promoted a selective
separation of a mixture of hydrophilic allergens (major for
health care workers) in pHCW fractions, whereas a mixture
of hydrophobic allergens was found in peaks 2 and 3
(Table 2).
Skin testing
The ability of latex glove extracts to induce reactions in vivo
was demonstrated by SPT in 14 participants with a clinical
diagnosis of latex allergy (seven health care workers and seven
patients with spina bifida), using extracts from internal and
external glove surfaces and also extracts enriched in the major
allergens for patients with spina bifida (pPSB) and health care
workers (pHCW).
Table 2 Quantification of allergens Hev b 1, Hev b 3, Hev b 5, Hev b
6Æ02 by enzyme immunoassay of latex glove extracts. Precipitates, P1,
P2 and P3, were obtained by selective precipitation with 25%, 50%
and 75% ammonium sulphate. Peak 1, peak 2 and peak 3 were











28Æ2 14Æ1 283Æ1 250Æ0
External
extract
55Æ7 54Æ0 29Æ0 317Æ8
Selective precipitation
P1 (pPSB)b 49Æ16 26Æ41 0 5Æ10
P2b 8Æ26 0 1Æ22 6Æ65




0 0 3Æ11 7Æ65
Peak 2 12Æ50 0 0 6Æ09
Peak 3 6Æ05 6Æ05 0 6Æ76
aFITKit. bPrecipitation steps 1, 2 and 3.
Table 3 Skin prick test results of 14 participants using a commercial extract and specially prepared latex glove extracts (internal surface, external

























1 (HCW) + ) + ) + + )
2 (HCW) +++ + +++ ++ +++ + )
3 (HCW) + ) ) ) + + )
4 (HCW) + ) + ) + + )
5 (HCW) + ) + ) + + )
6 (HCW) + ) ++ + + + )
7 (HCW) + ) ++ + + + )
8 (PSB) ) + + ++ + + )
9 (PSB) + ++ + +++ + + )
10 (PSB) + + ) ++ ++ + )
11 (PSB) ) ++ + ++ + + )
12 (PSB) + ++ ) ++ ++ + )
13 (PSB) ) ) ) ) ) + )
14 (PSB) ) ) ) ) ) + )
+, Positive reaction: weal diameter ‡ 3 mm; ++, positive reaction: weal diameter ‡ 5 mm; +++, highly positive reaction: weal diameter
> 15 mm; ), negative reaction: weal diameter < 2 mm; HCW, health care worker; PSB, patient with spina bifida.
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The results showed that all the health care workers had
positive SPT to extracts from the internal surfaces of the gloves
but had no detectable skin reactivity to the external surfaces,
except subject 2, who had a small reaction to this extract
(Table 3).
By contrast, among patients with spina bifida who showed
positive SPT, all had higher reactivity to extracts from the
external surfaces of the gloves than to the internal ones, except
for patient 10, who had an equally positive reaction for both
extracts. Patients with spina bifida 9, 10 and 12, who have
serum Hev 6Æ01-specific IgE (Table 1), also showed slight re-
activity to internal extracts. Two patients with spina bifida
(patients 13 and 14) did not show any skin reactivity to the
extracts used for SPT. In fact, patient 13 had negative results
for all serum tests performed (Phadiatop, k82 and rHev b
allergens), but had positive clinical symptoms to latex-
enriched environments and to provocation tests with latex
gloves (Table 1). On the other hand, patient 14 is presently
asymptomatic, despite having high latex-specific IgE to total
latex extract k82 and to latex recombinant allergens.
Interestingly, all health care workers had positive SPT to
pHCW extract (enriched in the major allergens for health care
workers), with the exception of participant 3 who did not
show reactivity to either of the enriched extracts, pHCW or
pPSB (Table 3). Additionally, health care workers who only
had serum-specific IgE to Hev b 8 (participants 1, 3 and 5)
showed a lower degree of skin reactivity to the extracts used,
being always negative for the external glove extract and for
pPSB. It is noteworthy that health care workers who had
serum-specific IgE to Hev b 6Æ02 (participants 2, 6 and 7) also
showed reactivity to pPSB (Tables 1 and 3). Patients with
spina bifida showed a strongly positive reaction to this
enriched extract, confirming the results obtained for latex
glove extracts from external surfaces.
It should be noted that SPT using enriched latex glove
extracts, with a total protein concentration of 400 lg mL)1,
had similar or, in five participants, higher skin reactivity than
that obtained with the commercial latex extract although this
had a higher protein concentration, 1000 lg mL)1 (Table 3).
An illustrative photograph of the forearm of patient 8 after
SPT with the latex glove extracts produced in this study is
shown in Fig. 1.
Discussion
On the basis of the evidence of environmental latex sensitizat-
ion, our data indicates that differential contact with latex
gloves may be associated with different in vivo allergen reactiv-
ity profiles in health care workers and in patients with spina
bifida. Despite the great variability that is usually found
between SPT and serum latex-specific IgE in patients and
others, we observed a different pattern of reactivity for each
latex risk group in this work.
This study has novel in vivo data showing that, in general,
health care workers have a higher SPT reactivity to allergens
from the internal surfaces of latex gloves and to the enriched
hydrophilic extracts pHCW, whereas patients with spina bifida
showed stronger positive skin reactions to allergens from
external surfaces and to the enriched hydrophobic extracts
pPSB (Table 3). Patient 13, who did not have skin reactivity
to latex extracts, did not have serum reactivity to any
recombinant latex allergens. These results may suggest that his
clinical symptoms were triggered by nonlatex components of
the gloves. On the other hand, serological and SPT results
from patient 14 could indicate the presence of sensitization to
latex allergens in the absence of clinically relevant allergic
symptoms.
It is interesting to observe that patients with spina bifida
with elevated serum levels of specific IgE to Hev b 5
and ⁄or Hev b 6Æ01 (patients 8, 9, 10 and 12) also showed
mild skin reactivity to extracts from internal glove surfaces
and ⁄or to the enriched hydrophilic pHCW extracts, as these
allergens are expected to be present mainly in these
extracts.
The high concentration of Hev b 6Æ02 in all the extracts
studied (Table 2) confirmed the widespread presence of this
allergen in latex products,19,20 and may explain the reactivity
of health care workers 2, 6 and 7 to the hydrophobic pPSB
extract (Table 3). In fact, all these subjects showed the pres-
ence of serum Hev b 6Æ02 specific IgE (Table 1).
Although some participants had a clinical history of latex
allergy associated with positive SPT to latex extracts they did
not show any positive latex extract-specific IgE levels (subject
4). In fact, it is known that some patients with allergic disease
are classified as having false-negative IgE antibody test results,
and, in addition, the presence of IgE antibodies is necessary
but not sufficient for the expression of allergic disease.21 In
fact, the immunological mechanisms underlying biological
reactivity to latex glove allergens in subject 4 may be non-IgE
mediated.
Fig 1. Skin prick test results of a patient with spina bifida (patient 8):
1 Commercial latex extract; 2 External glove surface extract; 3 Positive
control; 4 Glove extract enriched with hydrophobic major allergens
(pPSB) for patients with spina bifida; 5 Glove extract enriched with
hydrophilic major allergens (pHCW) for health care workers; 6
Internal glove surface extract; 7 Negative control.
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Moreover, some allergic patients are known to respond
differently to recombinant extracts with different combin-
ations of allergens that are identical except for minor differ-
ences in their primary amino acid composition.22 In fact,
recombinant allergens that do not represent all isoallergen
forms might not be able to detect all clinically relevant IgE
antibodies.21 On the other hand, allergens extracted from
their natural sources may be heterogeneous and often contain
nonallergic proteins. It was reported that natural extracts also
vary in their allergen composition and potency.23 Overall,
SPT results suggest that preferential contact with the internal
surfaces of latex gloves by health care workers may represent
the main route of sensitization in this risk group. In fact, the
previous work of our research group showed a different
allergen composition in the inner and outer surfaces of latex
gloves, suggesting a relationship between latex allergen loca-
tion and sensitization routes in latex risk groups.16,17 It is
known that health care workers make direct contact with the
internal surface of latex gloves and with aerosolized glove
powder and have clinical manifestations such as contact
dermatitis, nasal and ocular pruritus, wheezing, dyspnoea,
cough and increased bronchial secretions.24 By contrast, the
main route of senzitization of patients with spina bifida is
the direct contact with the external surfaces of latex gloves
during surgical procedures.
Genetic factors may also be related to latex allergy in health
care workers.14 According to Brown et al.,12 the significant
association of IL-13 and IL-18 promoter polymorphisms with
latex allergy may suggest a potential location for genetic con-
trol in the induction of latex allergy in health care workers.
Rihs et al.13 also showed that HLA-DQ8 and HLA-DQ8-DR4
haplotypes are positively associated with specific immune
responses to Hev b 6Æ02 in health care workers with latex
allergy, but not in patients with spina bifida.
In patients with spina bifida, the number of surgical proced-
ures rather than the spina bifida per se, is related to sensitization
to latex.15,25 In fact, currently, latex allergy in children with
spina bifida is regarded as a multifactorial situation associated
with a propensity towards latex sensitization, early exposure
and number of surgical procedures.26 Overall, apart from possi-
ble genetic factors, environmental factors play a crucial role in
the development of NRL sensitization, for both health care
workers and patients with spina bifida.14 In this regard, our
data suggest that the key question concerns the different routes
of exposure for different risk groups for latex allergy.
Another interesting and important feature of this study was
the preparation of enriched extracts with major allergens for
the latex risk groups using selective precipitation and HIC. SPT
results showed that our extracts exhibit good allergenic capac-
ity and good specificity for in vivo diagnosis, even though they
contain less than half of the protein concentration in the com-
mercial latex extract (Table 3). This is very important as we
were able to detect sensitization to latex allergens in all the
participants who had latex-related symptoms, which suggests
that our extracts are sensitive enough for diagnosis and also
decrease the exposure of different risk groups to allergens that
are less relevant for the risk group-oriented diagnosis (e.g.
health care workers can be sufficiently diagnosed as latex sen-
sitive using only the extracts from the inner glove surface,
thereby avoiding unnecessary exposure to extracts from the
outer surface). These novel findings will be further evaluated
with a larger number of patients.
Our study also emphasized the potential of selective precipi-
tation and HIC in the separation of latex allergens by perform-
ing breakthrough experiments in order to produce latex
extracts that are specific to the latex risk groups and which
were obtained directly from the source of allergens, latex
gloves. Selective precipitation and HIC were applied with the
purpose of taking advantage of the different hydrophobicities
shown by the major latex allergens in health care workers,
Hev b 2, Hev b 5, Hev b 6Æ01 and Hev b 13, which have
mainly hydrophilic characteristics, and in patients with spina
bifida, Hev b 1 and Hev b 3, which are hydrophobic.9–11
Although this technique is not highly specific, in this study it
was applied for both the enrichment and concentration of
latex allergens. Thus, salt precipitation of glove latex extract
promoted a selective separation and enrichment in the hydro-
phobic major allergens seen in patients with spina bifida in
the pPSB fraction (Table 2). As discussed above, the presence
of Hev b 6Æ02 in almost all fractions is justified by its abun-
dance and widespread presence in latex,19,20 which made the
purification process difficult. HIC results showed a selective
separation of hydrophilic major allergens in the pHCW frac-
tion (Table 2), which holds potential for the health care
workers risk group.
Based upon the differential latex-sensitization profiles in
both health care workers and patients with spina bifida,
specific latex glove extracts could represent an alternative
approach not only to a more targeted and effective diagnosis
of latex allergy but also to a more reliable and possibly safer
assessment than with conventional latex extracts.
In conclusion, our study showed, for the first time, in vivo a
differential skin reactivity of health care workers and patients
with spina bifida to the internal and external surfaces of rub-
ber latex gloves and to extracts enriched in the major latex
allergens. This suggests that differential contact with latex
glove surface allergens may be associated with different re-
activity profiles to latex allergens in health care workers and
patients with spina bifida.
What is already known about this topic?
• We have previously shown that there are substantial
differences in the composition of latex allergen profiles
between the internal and external surfaces of natural rub-
ber latex gloves.
• Concentrations of Hev b 1 and Hev b 3, major allergens
for patients with spina bifida, were found to be signifi-
cantly higher on external surfaces, while internal sur-
faces had higher levels of the major allergens for health
care workers, Hev b 5 and Hev b 6Æ02.
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What does this study add?
• Novel data on a differential in vivo reactivity pattern in
health care workers and patients with spina bifida to
internal and external glove extracts, which suggests that
sensitization by different routes of exposure may clearly
influence the reactivity profiles in these risk groups.
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